
Promaxo
Developer of a portable magnetic resonance imaging (MRI) system designed for improving prostate cancer diagnosis and treatment. The company's system integrates imaging, artificial intelligence, and ro...
Valuation
$0
Share Price
N/A
Total Raised
$80.8M
Last Round
N/A